ScopeCardiff and Vale University Health Board
99 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Department of Haematology, University Hospital of Wales, Heath Park
Cardiff CF14 4XW , United Kingdom
Cardiff CF14 4XW , United Kingdom
Accreditation
Active
UKAS
8985
wales.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8985
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDF
Test Capabilities (99)
| Standard Reference | Description | Category |
|---|---|---|
| ABO | ABO | Biological / Microbiological |
| Erythropoietin | Erythropoietin | Clinical Chemistry |
| Folate | Folate | Clinical Chemistry |
| Serum Iron | Serum Iron | Clinical Chemistry |
| Detection and Identification of Plasmodium species: Falciparum | Detection and Identification of Plasmodium species: Falciparum | Clinical Microbiology |
| MEASUREMENT | Measurement | Electrical |
| ADAMTS13 Assay (ADAMTS) | ADAMTS13 Assay (ADAMTS) | Hematology |
| Anti Factor Xa Assay (XA) measurement | Anti Factor Xa Assay (XA) measurement | Hematology |
| Assay (FAC8CHR) measurement | Assay (FAC8CHR) measurement | Hematology |
| Assay (PAN) | Assay (PAN) | Hematology |
| Assay (PLGCHR) | Assay (PLGCHR) | Hematology |
| Assay (PRSA) | Assay (PRSA) | Hematology |
| Assay (VWFAG) | Assay (VWFAG) | Hematology |
| Assessment of intracellular antigens during investigation of acute leukaemia, Lymphoproliferative disorders, and lymphoma | Assessment of intracellular antigens during investigation of acute leukaemia, Lymphoproliferative disorders, and lymphoma | Hematology |
| Blood Plasma | Human (FAC8INHU) | Human (FAC8INHU) | Hematology |
| Blood grouping, ABO and RhD systems | Blood grouping, ABO and RhD systems | Hematology |
| CD34+ and/or CD3 cell enumeration in therapeutic products used for Haemopoietic Stem Cell | CD34+ and/or CD3 cell enumeration in therapeutic products used for Haemopoietic Stem Cell | Hematology |
| DCT and identification of coating measurement | DCT and identification of coating measurement | Hematology |
| Detection and Quantification of Haemoglobin Fractions: HbA, HbA2, HbS, HbD, HbE, HbC, HbF, HbO Arab, Hb | Detection and Quantification of Haemoglobin Fractions: HbA, HbA2, HbS, HbD, HbE, HbC, HbF, HbO Arab, Hb | Hematology |
| Detection and characterisation of B-cell Lymphoproliferative disorders | Detection and characterisation of B-cell Lymphoproliferative disorders | Hematology |
| Detection and characterisation of T-cell/NK-cell | Detection and characterisation of T-cell/NK-cell | Hematology |
| Detection and characterisation of plasma cell disorders (Myeloma, Monoclonal Gammopathy of Unknown Significance) and Plasmacytoma measurement | Detection and characterisation of plasma cell disorders (Myeloma, Monoclonal Gammopathy of Unknown Significance) and Plasmacytoma measurement | Hematology |
| Detection and characterisation of acute leukaemia and enumeration of blasts and monocytes in Myelodysplastic syndrome | Detection and characterisation of acute leukaemia and enumeration of blasts and monocytes in Myelodysplastic syndrome | Hematology |
| Detection and identification of the following Antibodies: ABO blood group antibodies: anti-A, Processing samples for blood grouping anti-B and antibody screening on Ortho Vision BT 108: Processing for Blood Grouping Rh blood group antibodies: anti-Cw, and Antibody Screening on the Ortho anti-C, anti-c, anti-E, anti-e, anti-D Vision Kell blood group antibodies: anti-K, anti-k, anti-Kpa Or Manual blood grouping by Ortho SOP MNSs blood group antibodies: anti-M, BT 120: Manual Blood Grouping by anti-N, anti-S, anti-s Ortho Duffy blood group antibodies: anti-Fya, anti-Fyb BT 126: Antibody Investigation by Ortho Kidd blood group antibodies: anti-Jka, anti-Jkb | Detection and identification of the following antibodies: • Rhesus blood group antibodies D, C, E, c, e, f, Cw and V Compatibility testing: Compatibility testing of patients Plasma with donor cells measurement | Hematology |
| Detection of C, c, E, e and K antigens | Detection of C, c, E, e and K antigens | Hematology |
| ESR measurement | ESR measurement | Hematology |
| Eosin-5-Malemide dye binding test, screening test for Hereditary Spherocytosis | Eosin-5-Malemide dye binding test, screening test for Hereditary Spherocytosis | Hematology |
| FBC | FBC | Hematology |
| Factor II Assay (FAC2) | Factor II Assay (FAC2) | Hematology |
| Factor IX Assay (FAC9) | Factor IX Assay (FAC9) | Hematology |
| Factor IX Inhibitor Assay (FAC9INH) | Factor IX Inhibitor Assay (FAC9INH) | Hematology |
| Factor V Assay (FAC5) | Factor V Assay (FAC5) | Hematology |
| Factor VII Assay (FAC7) | Factor VII Assay (FAC7) | Hematology |
| Factor VIII Assay (FAC8) | Factor VIII Assay (FAC8) | Hematology |
| Factor VIII Bovine Inhibitor | Factor VIII Bovine Inhibitor | Hematology |
| Factor VIII Bovine chromogenic assay | Factor VIII Bovine chromogenic assay | Hematology |
| Factor VIII Chromogenic | Factor VIII Chromogenic | Hematology |
| Factor X Assay (FAC10) | Factor X Assay (FAC10) | Hematology |
| Factor XI Assay (FAC11) | Factor XI Assay (FAC11) | Hematology |
| Factor XII Assay (FAC12) | Factor XII Assay (FAC12) | Hematology |
| Factor XIII Antigen Assay | Factor XIII Antigen Assay | Hematology |
| Factor XIII Assay | Factor XIII Assay | Hematology |
| G6 PD deficiency screen measurement | G6 PD deficiency screen measurement | Hematology |
| Haemanitics: Vitamin B12 | Haemanitics: Vitamin B12 | Hematology |
| Haematological examination activities for the purpose of clinical diagnosis | Haematological examination activities for the purpose of clinical diagnosis | Hematology |
| Haematology patients (post BMT or on chemotherapy) | Haematology patients (post BMT or on chemotherapy) | Hematology |
| Haemoglobinopathy examination activities for the purpose of clinical diagnosis | Haemoglobinopathy examination activities for the purpose of clinical diagnosis | Hematology |
| Immunoplatelet counting measurement | Immunoplatelet counting measurement | Hematology |
| Kleihauer to detect foeto/maternal haemorrhage | Kleihauer to detect foeto/maternal haemorrhage | Hematology |
| Lepore, HbH, HbBarts, delta chain variants, uncharacterised haemoglobin variants | Lepore, HbH, HbBarts, delta chain variants, uncharacterised haemoglobin variants | Hematology |
| Lepore, delta chain variants, uncharacterised haemoglobin variants | Lepore, delta chain variants, uncharacterised haemoglobin variants | Hematology |
| Measurable residual disease detection in acute leukaemia | Measurable residual disease detection in acute leukaemia | Hematology |
| Morphological assessment of cell types present in CSF samples measurement | Morphological assessment of cell types present in CSF samples measurement | Hematology |
| Plasminogen Chromogenic | Plasminogen Chromogenic | Hematology |
| Platelet Adenine Nucleotide | Platelet Adenine Nucleotide | Hematology |
| Platelet Aggregation Studies (PLTAGG) von Willebrand Factor Ristocetin Cofactor (VWRIC) | Platelet Aggregation Studies (PLTAGG) von Willebrand Factor Ristocetin Cofactor (VWRIC) | Hematology |
| Protein C Functional Assay (PRCA) | Protein C Functional Assay (PRCA) | Hematology |
| Protein S Immunological | Protein S Immunological | Hematology |
| Qualitative Visual Assessment and Confirmation of Haemoglobin Fractions: HbA, HbA2, HbS, HbD, HbE, HbC, HbF, HbO Arab, Hb | Qualitative Visual Assessment and Confirmation of Haemoglobin Fractions: HbA, HbA2, HbS, HbD, HbE, HbC, HbF, HbO Arab, Hb | Hematology |
| Ristocetin Induced Platelet | Ristocetin Induced Platelet | Hematology |
| Routine Haemostasis: APTT | Routine Haemostasis: • OSPT • APTT • APTT Ratio • Fibrinogen. • INR • D-Dimer • Heparin Screen (TCT) measurement | Hematology |
| Sickle Solubility Screening | Sickle Solubility Screening | Hematology |
| Silica Clotting Time (SCT) | Silica Clotting Time (SCT) | Hematology |
| Von Willebrand factor GP1bR binding assay | Von Willebrand factor GP1bR binding assay | Hematology |
| Detection of normal and abnormal morphologies | Detection of normal and abnormal morphologies | Histopathology / Cytology |
| Antibody Screen and Identification to detect: Rh – anti-D, anti-C, anti-c, anti- E, anti-e, anti-V, anti-C W | Antibody Screen and Identification to detect: Rh – anti-D, anti-C, anti-c, anti- E, anti-e, anti-V, anti-C W | Immunology / Serology |
| Antigen detection: Kell – K | Antigen detection: Kell – K | Immunology / Serology |
| Assay (BOV8INSHU) | Assay (BOV8INSHU) | Immunology / Serology |
| Cold agglutinin screen measurement | Cold agglutinin screen measurement | Immunology / Serology |
| Crossmatch (compatibility testing) | Crossmatch (compatibility testing): Serological IAT Crossmatch | Immunology / Serology |
| Duffy – Fya, Fyb | Duffy – Fya, Fyb | Immunology / Serology |
| Duffy – anti-Fy a , anti-Fy b | Duffy – anti-Fy a , anti-Fy b | Immunology / Serology |
| Heparin/PF4 Antibody ELISA (HITEL) | Heparin/PF4 Antibody ELISA (HITEL) | Immunology / Serology |
| Immunophenotyping examination activities for the purpose of clinical diagnosis | Immunophenotyping examination activities for the purpose of clinical diagnosis | Immunology / Serology |
| Intrinsic Factor Antibodies | Intrinsic factor antibodies | Immunology / Serology |
| Kell – anti-K, anti-k, anti-Kp a , anti-Kp b , anti-Js a , anti-Js b | Kell – anti-K, anti-k, anti-Kp a , anti-Kp b , anti-Js a , anti-Js b | Immunology / Serology |
| Kidd – anti-Jk a , anti-Jk b | Kidd – anti-Jk a , anti-Jk b | Immunology / Serology |
| Lewis – Lea, LebP1, M, N, S, s | Lewis – Lea, LebP1, M, N, S, s | Immunology / Serology |
| Lewis – anti-Le a , anti-Le b anti-P1, anti-M, anti-N, anti-S, anti-s Lutheran – anti-Lu a , anti-Lu b anti-Xg a | Lewis – anti-Le a , anti-Le b anti-P1, anti-M, anti-N, anti-S, anti-s Lutheran – anti-Lu a , anti-Lu b anti-Xg a | Immunology / Serology |
| Lymphocyte subset enumeration in immunocompromised | Lymphocyte subset enumeration in immunocompromised | Immunology / Serology |
| Lymphoproliferative disorders | lymphoproliferative disorders: | HMDS-FLO-SOP-2 | Immunology / Serology |
| RhD | RHD | Molecular Diagnostics / PCR |
| ADAMTS-13 Inhibitor Assay | ADAMTS-13 Inhibitor Assay | Other |
| Aggregation (RIPA) | Aggregation (RIPA) | Other |
| Antithrombin Activity Assay (ATAA) | Antithrombin Activity Assay (ATAA) | Other |
| Apixaban Assay (APIXA) | Apixaban Assay (APIXA) | Other |
| Blood Grouping | Blood grouping: | IPS_Trans_LPT_20 Routine use of | Other |
| Blood Transfusion activities for the purpose of clinical diagnosis | Blood Transfusion activities for the purpose of clinical diagnosis | Other |
| Dabigatran Assay (DAB) | Dabigatran Assay (DAB) | Other |
| Detection of mononucleosis measurement | Detection of mononucleosis measurement | Other |
| Emicizumab Assay | Emicizumab Assay | Other |
| Factor VIII Inhibitor Assay | Factor VIII inhibitor assay | Other |
| Haemostasis and thrombosis examination activities for the purpose of clinical diagnosis | Haemostasis and thrombosis examination activities for the purpose of clinical diagnosis | Other |
| Kidd – JKa, Jkb | Kidd – JKa, Jkb | Other |
| Lupus Anticoagulant Screen (LAS) | Lupus Anticoagulant Screen (LAS) | Other |
| Rivaroxaban Assay (RIVA) | Rivaroxaban Assay (RIVA) | Other |
| Total Iron Binding Capacity | Total Iron Binding Capacity | Other |
| Transplantation | Transplantation | Other |
| Ferritin | Ferritin | Spectroscopy (XRF, ICP, AAS) |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.